'Drug may have caused huge number of deaths': Lessons learned during an encounter with The Fifth Estate

CMAJ. Canadian Medical Association Journal

Volumn 155, Issue 6, 1996, Pages 772-775

  Myers, Martin G ^a,b  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; NIFEDIPINE;

DRUG FATALITY; DRUG SAFETY; SHORT SURVEY; TELEVISION;

EID: 0029837822     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (12)

1. Myers MC, Carruthers SG, Leenen FHH, Haynes RB: Canadian Hypertension Society Consensus Conference on the Pharmacologic Treatment of Hypertension. Can Med Assoc J 1989;140:1141-6.
2. Ogilvie RI, Burgess ED, Cusson JR, Feldman RD, Leiter LA, Myers MG: Report of the Canadian Hypertension Society Consensus Conference: 3. Pharmacologic treatment of essential hypertension. Can Med Assoc J 1993;149:575-84.
3. Myers MG: New drugs for hypertension: Should data precede conclusions? Can Med Assoc J 1990;143: 265-6.
4. Myers MG, Baigrie RS, Dubbin JD: Nifedipine versus propranolol treatment of unstable angina in the elderly. Can J Cardiol 1988;4:402-6.
5. Myers MG, Leenen FHH, Burns R, Frankel D: Nifedipine tablet vs hydralazine in patients with persisting hypertension who receive combined diuretic and beta-blocker therapy. Clin Pharmacol Ther 1986;39:409-13.
6. Myers MG, Raemsch KD: Comparative pharmacokinetics and antihypertensive effects of the nifedipine tablet and capsule. J Cardiovasc Pharmacol 1987;10 (suppl X): 576-8.
7. Myers MG, Leenen FHH, Tanner J: Differential effects of felodipine and nifedipine on 24-hour blood pressure and left ventricular mass. Am J Hypertension 1995;8:712-8.
8. Myers MG, Toal CB on behalf of the SWITCH Study investigators: Comparative efficacy of two long-acting formulations of nifedipine in the treatment of hypertension, Can J Cardiol 1995;11:913-7.
9. Psaty BM, Heclbert SR, Koepsell TD et al: The risk of myocardial infarction associated with antihypertensive therapy. JAMA 1995;274: 620-5.
10. Furberg CD, Psaty BM, Meyer JV: Nifedipine. Dose-related increase in mortality in patients with coronary heart disease. Circulation 1995;92: 1326-31.
11. The Multicenter Diltiazem Postinfarction Trial Research Group: The effect of diltiazem on mortality and reinfarction after myocardial infarction. N Engl J Med 1988;319:385-92.
12. The Danish Study Group on Verapamil in Myocardial Infarction. Effect of verapamil on mortality and major events after acute myocardial infarction (the Danish Verapamil Infarction Trial II - DAVIT II). Am J Cardiol 1990,66:779-85.